
Drug May Prevent Infertility in Males Undergoing Cancer Treatment
G-CSF promotes regeneration of sperm cells in cancer patients.
A drug used to prevent infection in patients with cancer may also prevent male infertility, according to a
The loss of fertility is a common problem among male cancer patients, because treatments often halt sperm production.
While looking for ways to restart sperm production, investigators discovered a link between the drug granulocyte colony-stimulating factor (G-CSF) and the absence of typical damage to reproductive ability.
G-CSF is a biologic response modifier that stimulates granulocyte production in patients undergoing chemotherapy. It is designed to prevent infection and neutropenic fevers typically caused by cancer treatment.
“We are using G-CSF to prevent infections in our research experiments,” said lead investigator Brian Hermann. “It turned out that the drug also had the unexpected impact of guarding against male infertility.”
In a study using male mice treated with G-CSF, the investigators found that the drug unexpectedly began regenerating sperm production by creating new sperm cells to replace the dead cells.
“Granulocyte colony-stimulating factor appears to promote proliferation of undifferentiated spermatogonia, which leads to a modest enhancement of spermatogenic regeneration from surviving spermatogonia after high-dose alkylating chemotherapy,” the authors wrote. “G-CSF treatment alone also enhances spermatogenic parameters, suggesting a role in steady-state spermatogenesis.”
Future steps would include determining whether G-CSF has a correlation with improved
“Male infertility is an intuitive disease and we need creative solutions,” Hermann concluded. “But we need to understand how things work before we can fix them.”






































































































































